Therefore Nrf2 activation has emerged as an attractive therapeutic approach to develop new classes of drugs as therapeutic treatment for a myriad of diseases and this includes inflammation, chronic multiple sclerosis, kidney disease, pulmonary fibrosis, cancer and chronic obstructive pulmonary disease (COPD) [25–32]. The gene discussed is NFE2L2; the disease is chronic obstructive pulmonary disease.